Connect Biopharma Holdings Limited (CNTB) vs ImageneBio Inc (IMA)
A side-by-side comparison of Connect Biopharma Holdings Limited and ImageneBio Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.96HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
IMA
ImageneBio Inc
$4.81HealthcareDelayed quote: Oct 6, 2026, 10:56 AM EDT
Total return — CNTB vs IMA
growth of $100 · dividends reinvested · last 6yCNTB -94.4% (-38.1%/yr)IMA -98.8% (-52.0%/yr)CNTB compounded faster over this window
CNTB IMA
CNTB vs IMA: by the numbers
- •CNTB is the larger company ($60M vs $54M market cap).
- •Both run net losses; IMA's is the smaller (-5668.62% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | IMA |
|---|---|---|
| P/B ratio | 2.24 | 0.38 |
Profitability
| Metric | CNTB | IMA |
|---|---|---|
| Gross margin | 100.00% | -29.12% |
| Operating margin | -90740.62% | -6056.37% |
| Net margin | -86687.50% | -5668.62% |
| ROE | -132.16% | -36.94% |
| ROIC | -136.77% | -40.53% |
Growth (annualized)
| Metric | CNTB | IMA |
|---|---|---|
| Total return CAGR (5Y) | -47.22% | -50.73% |
Frequently asked
- How have CNTB and IMA total returns compared?
- Over the past 5 years, CNTB delivered -47.22% and IMA delivered -50.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.